China Pharmaceutical Regulatory Affairs Training Course: How to Gain and Maintain a Successful Marketing Authorisation in the PRC, Including Hong Kong, Macau and Taiwan (ONLINE EVENT)
January 09, 2025 09:12 ET
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in China Training Course" conference has been added to ResearchAndMarkets.com's offering. This seminar will provide...
Clinical Trials Management Systems (CTMS) Market Research, 2024-2035, by Solution Type, Component, Delivery Mode, End User, and Region with Detailed Company Profiles of Leading Players
January 03, 2025 07:29 ET
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trials Management System Market by Solution Type, by Component, by Delivery Mode, by End-User, and By Region" report has been added to ...
AI in Drug Discovery Strategic Intelligence Research Report 2024: Healthcare, Macroeconomic, Technology, and Regulatory Trends Impacts
December 20, 2024 09:49 ET
|
Research and Markets
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: AI in drug discovery" report has been added to ResearchAndMarkets.com's offering. This report consolidates the latest...
China Pioneers Innovative Drug Development with a Surge in CAR-T Cell and ADC Therapy Advancements
December 20, 2024 09:26 ET
|
Research and Markets
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Drug Development Trends in China" report has been added to ResearchAndMarkets.com's offering.China has emerged as a critical player in global drug...
Pharmaceutical Regulatory Affairs in China - 2 Day Online Training Course (March 31, 2025 April 1, 2025)
December 10, 2024 13:01 ET
|
Research and Markets
Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in China Training Course" has been added to ResearchAndMarkets.com's offering. This seminar will provide an...
CD40 Targeted Therapies Clinical Trials & Market Opportunity Report 2025, Insight By Company, Country, Indication & Phase
December 09, 2024 04:48 ET
|
Research and Markets
Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The "CD40 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2025" report has been added to ...
CD47 Inhibitor Drug Clinical Trials Market Outlook to 2028 - Emerging CD47 Inhibitor Clinical Trials Showcase Potential Cancer Treatment Breakthroughs
September 06, 2024 06:48 ET
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028" report has been added to ResearchAndMarkets.com's offering....
Pharmacovigilance Market - Global Forecasts from 2024 to 2029: Increased Prevalence of ADRs to Drive Expansion
August 16, 2024 07:13 ET
|
Research and Markets
Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Global Pharmacovigilance Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The global pharmacovigilance...
Global VISTA Inhibitor Clinical Trials & Market Opportunity Insight 2024: Widening Research Purview - From Cancer to Autoimmune Disorders
July 04, 2024 04:03 ET
|
Research and Markets
Dublin, July 04, 2024 (GLOBE NEWSWIRE) -- The "Global VISTA Inhibitor Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's offering. The...
Global LAG-3 Inhibitors Market, Drug Sales & Clinical Trials Market Report: Featuring Abeome, ABL Bio, Agenus, Akeso Biopharma, AnaptysBio, EpimAb Biotherapeutics, Immutep, Incyte and Y-Biologics
June 20, 2024 04:23 ET
|
Research and Markets
Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Global LAG-3 Inhibitors Market, Drug Sales & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering. In recent...